Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Description

Eligible older adults with Type 2 Diabetes-Mild Cognitive Impairment (T2D-MCI) will be provided a Continuous Glucose Monitoring (CGM) device and asked to share CGM data with their care partners for daily decision-making for diabetes self-management. After 2 weeks, individual interviews will be conducted in 20 participants (10 dyads). Older adults with T2D-MCI (n=10) and their care partners (n=10) will be interviewed separately to identify key features of the Care Partner-Assisted Intervention through linking continuous glucose monitoring and Mobile Health (CP-CGMH) app.

Conditions

Type 2 Diabetes, Mild Cognitive Impairment

Talk to us

Study Overview

On this page

Study Details

Study overview

Eligible older adults with Type 2 Diabetes-Mild Cognitive Impairment (T2D-MCI) will be provided a Continuous Glucose Monitoring (CGM) device and asked to share CGM data with their care partners for daily decision-making for diabetes self-management. After 2 weeks, individual interviews will be conducted in 20 participants (10 dyads). Older adults with T2D-MCI (n=10) and their care partners (n=10) will be interviewed separately to identify key features of the Care Partner-Assisted Intervention through linking continuous glucose monitoring and Mobile Health (CP-CGMH) app.

CP-CGMH: Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Condition
Type 2 Diabetes
Intervention / Treatment

-

Contacts and Locations

New York

Bellevue Hospital, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. be ≥ 65 years old;
  • 2. have had a diagnosis of T2D for at least one year;
  • 3. have MCI, defined as score 19-25 on the Montreal Cognitive Assessment (MoCA);60,61
  • 4. have a care partner (e.g., spouse or adult children);
  • 5. be willing to use CGM;
  • 6. be fluent in English.
  • 1. ≥ 18 years old;
  • 2. living with older adults with T2D-MCI;
  • 3. willing to be involved in patients' daily care;
  • 4. fluent in English.
  • 1. Refuse or are unable to provide informed consent;
  • 2. Have serious physical illness (e.g., end-stage renal disease);
  • 3. Presence of mental illness (e.g., schizophrenia or bipolar disorder) that would preclude participation.
  • 1. Refuse or are unable to provide informed consent;
  • 2. Have MCI.

Ages Eligible for Study

65 Years to 100 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Yaguang Zheng, PhD, RN, PRINCIPAL_INVESTIGATOR, Rory Meyers College of Nursing

Study Record Dates

2027-08-31